Total Payments
$11,074
2024 Payments
$4,216
Companies
36
Transactions
591
Medicare Patients
2,029
Medicare Billing
$190,699
Payment Breakdown by Category
Food & Beverage$10,817 (97.7%)
Education$256.98 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,817 | 588 | 97.7% |
| Education | $256.98 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,430 | 157 | $0 (2024) |
| Amgen Inc. | $1,779 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,072 | 54 | $0 (2024) |
| UCB, Inc. | $746.02 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $710.50 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $525.28 | 29 | $0 (2024) |
| Lilly USA, LLC | $500.20 | 20 | $0 (2024) |
| Horizon Therapeutics plc | $367.64 | 20 | $0 (2023) |
| PFIZER INC. | $351.22 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $345.87 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,216 | 208 | Amgen Inc. ($928.16) |
| 2023 | $4,008 | 215 | ABBVIE INC. ($975.63) |
| 2022 | $2,378 | 136 | ABBVIE INC. ($658.81) |
| 2021 | $472.06 | 32 | Fresenius USA Marketing, Inc. ($189.57) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.99 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $3.23 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Rheumatology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/12/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 531 | 859 | $118,769 | $39,450 |
| 2022 | 7 | 351 | 531 | $100,328 | $29,667 |
| 2021 | 10 | 452 | 703 | $209,777 | $47,681 |
| 2020 | 8 | 695 | 1,206 | $326,702 | $73,901 |
Total Patients
2,029
Total Services
3,299
Medicare Billing
$190,699
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 482 | $100,738 | $33,606 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 71 | $10,082 | $3,835 | 38.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 21 | $3,225 | $878.63 | 27.2% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 13 | 14 | $1,768 | $463.79 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 32 | $1,664 | $255.78 | 15.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 25 | 28 | $448.00 | $231.51 | 51.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 211 | $844.00 | $178.77 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 235 | $49,115 | $18,735 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 86 | $18,450 | $3,849 | 20.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 46 | $14,112 | $3,065 | 21.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $12,526 | $2,579 | 20.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 15 | $2,838 | $724.11 | 25.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 11 | 13 | $2,827 | $619.84 | 21.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 115 | $460.00 | $96.00 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 168 | 343 | $73,584 | $16,035 | 21.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 57 | 60 | $35,789 | $7,582 | 21.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 83 | $25,463 | $5,577 | 21.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 21 | 23 | $16,127 | $4,475 | 27.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 19 | 19 | $15,878 | $4,471 | 28.2% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 61 | 87 | $18,920 | $4,082 | 21.6% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 12 | 13 | $7,023 | $1,725 | 24.6% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 13 | 27 | $6,807 | $1,518 | 22.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $6,465 | $1,414 | 21.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 19 | 32 | $3,721 | $800.64 | 21.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 285 | 690 | $142,441 | $32,693 | 23.0% |
About Lee Matlock, APRN
Lee Matlock, APRN is a Family healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2017. The National Provider Identifier (NPI) number assigned to this provider is 1467990820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lee Matlock, APRN has received a total of $11,074 in payments from pharmaceutical and medical device companies, with $4,216 received in 2024. These payments were reported across 591 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,817).
As a Medicare-enrolled provider, Matlock has provided services to 2,029 Medicare beneficiaries, totaling 3,299 services with total Medicare billing of $190,699. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tulsa, OK
- Active Since 02/06/2017
- Last Updated 04/18/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467990820
Products in Payments
- RINVOQ (Biological) $1,546
- Enbrel (Biological) $1,139
- SAPHNELO (Biological) $980.24
- SKYRIZI (Biological) $781.74
- Cimzia (Drug) $673.58
- KRYSTEXXA (Biological) $611.98
- TREMFYA (Drug) $509.29
- TALTZ (Drug) $500.20
- COSENTYX (Drug) $403.23
- ACTHAR (Biological) $331.82
- XELJANZ (Drug) $306.47
- LUPKYNIS (Drug) $290.05
- OFEV (Drug) $281.64
- BENLYSTA (Biological) $268.38
- TAVNEOS (Drug) $266.40
- PURIFIED CORTROPHIN GEL (Drug) $255.26
- REMICADE (Biological) $201.21
- Velphoro (Drug) $189.57
- COSENTYX (Biological) $122.05
- ORENCIA (Biological) $121.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tulsa
Mr. Jeremy Morgan, Aprn, APRN
Family — Payments: $33,967
Family $33,967
Candy Williams, Aprn, Cnp, APRN, CNP
Family — Payments: $14,546
Family $14,546
Jillian Oakleaf
Family — Payments: $11,209
Family $11,209
Mrs. Erin Rowan, Aprn, APRN
Family — Payments: $11,107
Family $11,107
Teresa Donnell, Aprn, APRN
Family — Payments: $9,114
Family $9,114
Cristina Barnes, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $9,107
Family $9,107